|
|||||
|
|
EPO-906 (Novartis) |
|
| Authors: | Galmarini Carlos María Dumontet Charles |
| Affiliation: | University Lyon, INSERM 590, 8 Avenue Rockefeller, 69373 Lyon, France. fgalma@rockefeller.univ-lyon1.fr |
| Abstract: | Novartis Pharma AG is developing EPO-906, an intravenous formulation microtubular depolymerization inhibitor (microtubule stabilizer), for the potential treatment of cancer. |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |